Abstract
As asthma symptoms worsen, patients typically rely on short-acting β2-agonist (SABA) rescue therapy, but SABAs do not address worsening inflammation, which leaves patients at risk for severe asthma...
Cite
CITATION STYLE
APA
Papi, A., Chipps, B. E., Beasley, R., Panettieri, R. A., Israel, E., Cooper, M., … Albers, F. C. (2022). Albuterol–Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. New England Journal of Medicine, 386(22), 2071–2083. https://doi.org/10.1056/nejmoa2203163
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free